STEMI patients with primary PCI do not require Cardiac ICU admission: JAHA Dr.Niharika Harsha B19 Sept 2022 8:00 PM ISTRecent research found that patients with ST-segment-elevation myocardial infarction (STEMI) who receive a primary percutaneous coronary intervention...
Health Bulletin 19/September/2022 Dr. Nandita Mohan19 Sept 2022 5:40 PM ISTHere are the top health news for the day:NCDRC exonerates Cardiologist, Hospital of Negligence in implating pacemaker The National Consumer Disputes...
NCDRC exonerates Cardiologist, Hospital of Negligence in implating pacemaker Barsha Misra18 Sept 2022 7:27 PM ISTNew Delhi: The National Consumer Disputes Redressal Commission (NCDRC) exonerated a Cardiologist and Manipur based hospital from charges of...
Dietary potassium intake linked with blood potassium concentration in patients with CKD: study Dr. Shravani Dali15 Sept 2022 9:15 AM ISTDietary potassium intake is linked with blood potassium concentration in patients with CKD according to a recent study published in the Journal of...
Neonates with low gestational age and birthweight at increased risk of elevated BP and CKD Jacinthlyn Sylvia13 Sept 2022 8:00 PM ISTUSA: In a new study published in the Clinical Journal of the American Society of Nephrology, it was shown that the risk of chronic kidney disease...
Zydus Lifesciences in-licenses critical drug MonoFerric for CKD patients from Pharmacosmos A/S of Denmark Ruchika Sharma9 Sept 2022 2:34 PM ISTMonoFerric is indicated for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or cannot be used or where...
Arterial stiffness not tied to chronic kidney disease progression in children: Study Dr. Kamal Kant Kohli7 Sept 2022 11:15 AM ISTGermany: Pulse wave velocity measurements of chronic renal disease in children aged 6 to 17 showed increased arterial stiffness, although neither eGFR...
AstraZeneca Forxiga gets Chinese nod to treat CKD with and without type 2 diabetes Ruchika Sharma6 Sept 2022 11:15 AM ISTForxiga (dapagliflozin) is a first-in-class, oral, once-daily SGLT2 inhibitor.
Zydus Lifecsciences begins Desidustat Phase IV trial in patients with CKD induced anemia Ruchika Sharma31 Aug 2022 12:30 PM ISTDesidustat is currently approved in India as Oxemia for the treatment of anemia in Chronic Kidney Disease (CKD) patients.
Bayer unveils drug for CKD associated with diabetes under brand name Kerendia Ruchika Sharma26 Aug 2022 11:15 AM ISTThe major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end stage renal disease or kidney failure.
Premature Coronary Artery Disease- Know it all Dr. Nandita Mohan25 Aug 2022 9:00 AM ISTPremature coronary artery disease (CAD) is an endemic in India. Researchers performed a study to identify risk factors, clinical presentation,...
Chronic kidney disease linked with spontaneous intracerebral hemorrhage, finds JAMA study Dr. Shravani Dali22 Aug 2022 8:00 PM ISTA causal association exists between chronic kidney disease and spontaneous intracerebral haemorrhage according to a recent study published in the...
